Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temocillin vs Carbapenems for ESBL Urinary Tract Infections
NCT03543436Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of temocillin in urinary tract infection (UTI), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Clinical and Microbiological Cure. Started Jan 2019; status: completed.
02
Drugs
temocillin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03543436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03543436.